12:00 AM
Dec 09, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Chikungunya fever vaccine: Phase I started

Themis began an Austrian Phase I trial to evaluate its Chikungunya fever vaccine in about 36...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >